CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 102 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2018. The put-call ratio across all filers is 2.89 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $597,000 | +76.6% | 256,431 | +115.5% | 0.52% | +22.2% |
| Q4 2017 | $338,000 | -15.5% | 118,969 | -14.9% | 0.42% | +685.2% |
| Q3 2017 | $400,000 | +27.4% | 139,774 | +10.1% | 0.05% | +14.9% |
| Q2 2017 | $314,000 | +15.4% | 126,989 | +68.8% | 0.05% | -2.1% |
| Q1 2017 | $272,000 | +12.9% | 75,237 | +10.6% | 0.05% | -33.3% |
| Q4 2016 | $241,000 | 0.0% | 68,024 | +14.3% | 0.07% | -38.5% |
| Q3 2016 | $241,000 | -7.7% | 59,537 | 0.0% | 0.12% | -39.7% |
| Q2 2016 | $261,000 | +301.5% | 59,537 | +245.2% | 0.19% | +115.6% |
| Q1 2016 | $65,000 | – | 17,247 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |